RDi joins the NHS’ North West London Pathology as a proud sponsor of the upcoming NWLP Symposium taking place in June 2024, to unite and maximise local and global benefits of the industry.
RDi specialises in partnering with the healthcare sector to develop and streamline the workflows of patient-centric healthcare and pathology. For over two decades, RDi has served the entire healthcare landscape, revolutionising the packaging, kitting and supply chain capabilities of laboratories, researchers, community partners and more.
Among this year’s tabletop lineup of NWLP Symposium sponsors is RDi, and as a healthcare and supply chain expert, we’re keen to share our knowledge of sample collection solutions to promote the continuum of change in the arena we support.
Our data-led supply chain technology and next-generation collection solutions continue to transform how pathology services are delivered, with healthcare and pharmaceutical service providers achieving sustainability objectives, social responsibilities and an accelerated diagnostic result.
This year’s event will be hosted by Dr Saghar Missaghian-Cully, Managing Director of North West London Pathology (NWLP). On Thursday 27th June, the annual, one day symposium will involve NHS, Research, industry and community partners addressing topics that surround the evolution of healthcare. A panel discussion involving RDi representative, Anthony Cell, Chief Commercial Officer, will also take place.
This opportunity for a dynamic exchange of knowledge and ideas will fuel inspiration and collaboration across healthcare and medical professionals. RDi is keen to share our expertise, invest in the future of global public health and support services which facilitate innovation.
Enabling access to reduced plastic UN3373-compliant packaging, our product and kitting range includes patented technology and designs intended for the transportation, reception and collection of biological samples. We encourage healthcare professionals to explore our existing kitting and consumable solutions as we look to launch our exciting new patient-centric sample solutions in our development pipeline.
This comprehensive range of products includes the urine collection device, safe2Pcanter, which boasts an impressive 95% reduction in plastic. The typical plastic content of competitor counterparts ranges from 13gm LDPE to 19gm LDPE, yet the safe2Pcanter achieves 1gm LDPE. Only 10% plastic and 100% recyclable with the removal of the plastic inner, the safe2Pcanter is one of many examples where RDi has prioritised the ESG goals of the sector, specifically a plastic-free healthcare system.
RDi pairs its unique product portfolio with advanced data management solutions to couple patient data with sampling solutions. This ensures the secure and compliant fulfilment of patient samples whilst also providing personalisation and data security to the sample journey.
Global pharmaceutical, and healthcare service providers can review, evaluate, and analyse their fulfilment chain through RDi data-led fulfilment solutions to highlight opportunities to improve sample collection and return rates. Identifying the roadblocks causing delays in patient diagnosis can encourage professionals across the sector to transform their approach to patient-centric sampling. We’re privileged to showcase our suite of products, services and hybrid models at Storey Club, Paddington Central, London. Sponsoring the NWLP Symposium actions are dedicated to the continuous improvement of patient-centred care.
